CAS No.:93793-83-0
Name: Roxatidine acetate hydrochloride
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 75mg/kg (75mg/kg) | BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: CYANOSIS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
dog | LD50 | oral | 100mg/kg (100mg/kg) | BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: CYANOSIS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
monkey | LD50 | intravenous | 50mg/kg (50mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
mouse | LD50 | intravenous | 83mg/kg (83mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
mouse | LD50 | oral | 509mg/kg (509mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
mouse | LD50 | subcutaneous | 384mg/kg (384mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
rabbit | LD50 | oral | 900mg/kg (900mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
rat | LD50 | intraperitoneal | 227mg/kg (227mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
rat | LD50 | intravenous | 110mg/kg (110mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
rat | LD50 | oral | 755mg/kg (755mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
rat | LD50 | subcutaneous | 595mg/kg (595mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 13, Pg. 1167, 1985. |
Consensus Reports:
SAFETY PROFILE:
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and HCl. See also ESTERS.
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Jai Radhe Sales
- Afine Chemicals Limited
- Simagchem Corporation
- CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
- Dayang Chem (Hangzhou) Co.,Ltd.
- LIDE PHARMACEUTICALS LIMITED
- ETA SCIENTIFIC Co.,Ltd
- FOND EVER CO.,LIMITED
- champharmacy
- Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
- Tocopharm Co., Ltd.
- Suzhou Howsine Biological Technology Co.,Ltd(expird)
- Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
- SOGA ENTERPRISES ASIA GROUP
- All Pro Corporation
- Keen Union International Limited
- Kesheng Chemical Co.,LTD.
- XI'AN CHUKANG BIOTECHNOLOGY CO.,LTD
- Chemieliva Pharmaceutical Co., Ltd.
- Shijiazhuang Sdyano Fine Chemical Co., Ltd
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione